Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events-Reference-Cited by-同舟云学术

Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events

Published:1999-09 Issue: Volume:147 Page:S17-S21
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Arntz Hans-Richard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial;Neaton;Arch. Intern. Med.,1992

2. Plasma cholesterol and mortality. The Whitehall Study;Smith;J. Am. Med. Assoc.,1992

3. Serum cholesterol concentration and coronary heart disease in a population with low cholesterol concentrations;Chen;BMJ,1991

4. The discovery and development of HMG-CoA reductase inhibitors;Endo;J. Lipid Res.,1992

5. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plaque Passivation and Endothelial Therapy;Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease;2011

2. The Potential Role of Statins in Pneumonia;Current Respiratory Medicine Reviews;2010-08-01

3. The Potential Role of Statins in Severe Sepsis;Sepsis;2008

4. Measurement of unbound pravastatin in rat blood and bile on the perspective of hepatobiliary excretion and its interaction with cyclosporin A and berberine;Analytica Chimica Acta;2005-08

5. Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients;Circulation Journal;2003